G1 THERAPEUTICS INC's ticker is and the CUSIP is 3621LQ909. A total of 3 filers reported holding G1 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56 | -63.9% | 39,500 | -36.9% | 0.00% | – |
| Q2 2023 | $155 | +93.8% | 62,600 | +108.0% | 0.00% | – |
| Q1 2023 | $80 | +166.7% | 30,100 | +428.1% | 0.00% | – |
| Q4 2022 | $30 | -100.0% | 5,700 | -14.9% | 0.00% | – |
| Q3 2022 | $83,000 | +5.1% | 6,700 | -58.4% | 0.00% | – |
| Q2 2022 | $79,000 | -78.9% | 16,100 | -67.3% | 0.00% | – |
| Q1 2022 | $374,000 | +246.3% | 49,300 | +365.1% | 0.00% | – |
| Q4 2021 | $108,000 | -84.7% | 10,600 | -66.2% | 0.00% | -100.0% |
| Q3 2021 | $705,000 | +2.5% | 31,400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $688,000 | +16.8% | 31,400 | +12716.3% | 0.00% | 0.0% |
| Q1 2021 | $589,000 | +183.2% | 245 | +111.2% | 0.00% | – |
| Q4 2020 | $208,000 | +10300.0% | 116 | +5700.0% | 0.00% | – |
| Q3 2020 | $2,000 | -83.3% | 2 | -60.0% | 0.00% | – |
| Q2 2020 | $12,000 | -60.0% | 5 | -82.1% | 0.00% | – |
| Q1 2020 | $30,000 | +1400.0% | 28 | +2700.0% | 0.00% | – |
| Q4 2019 | $2,000 | -77.8% | 1 | -75.0% | 0.00% | – |
| Q3 2019 | $9,000 | -40.0% | 4 | -20.0% | 0.00% | – |
| Q2 2019 | $15,000 | +200.0% | 5 | +400.0% | 0.00% | – |
| Q3 2018 | $5,000 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 34,500 | $352,000 | 0.00% |
| SIMPLEX TRADING, LLC | 10,600 | $108,000 | 0.00% |